Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparison of Corticosteroids Types, Dexamethasone, and Methylprednisolone in Patients Hospitalized With Covid-19: A Systematic Review and Network Meta-Analysis Publisher



Morsali M1 ; Doostiirani A1 ; Amini S2 ; Nazemipour M3 ; Mansournia MA3 ; Aliannejad R4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
  2. 2. Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Division of pulmonary and critical care, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Global Epidemiology Published:2023


Abstract

Background: COVID-19 is associated with severe pneumonia lung damage, acute respiratory distress syndrome (ARDS), and mortality. In this study, we aimed to compare corticosteroids' effect on the mortality risk in patients hospitalized with COVID-19. Methods: PubMed, Web of Science, Scopus, Cochrane Library, and Embase, were searched using a predesigned search strategy. Randomized controlled trials (RCTs) that had compared the corticosteroid drugs were included. The hazard ratio (HR) with a 95% confidence interval (CI) was used to summarize the effect size from the network meta-analysis (NMA). Results: Out of 329 retrieved references, 12 RCTs with 11,455 participants met the eligibility criteria in this review. The included RCTs formed one network with six treatments. In addition, five treatments in two RCTs were not connected to the network. Methylprednisolone + usual care (UC) versus UC decreased the risk of death by 0.65 (95% CI: 0.47, 0.90). Among treatments in the network the highest P-score (0.89) was related to Methylprednisolone + UC. Conclusion: Based on the results of this NMA it seems Methylprednisolone + UC to be the best treatment option in patients with COVID-ARDS and COVID pneumonia. © 2023
Other Related Docs
11. P-Value, Compatibility, and S-Value, Global Epidemiology (2022)
20. Statins in Adult Patients With Hiv, Medicine (United States) (2018)
29. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
33. Interaction Contrasts and Collider Bias, American Journal of Epidemiology (2022)
34. Case–Control Matching on Confounders Revisited, European Journal of Epidemiology (2023)
49. Causal Methods for Observational Research: A Primer, Archives of Iranian Medicine (2018)